TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13 April 1, 1994